The following is a summary of “Recognizing the Need for Goals of Care Conversations Among Critically Ill Surgical Patients,” ...
In the early, busy weeks of President Trump's administration, a new survey shows how Americans would define a healthy America ...
The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback